Brief: Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding Of Seven Clinically Relevant Covid-19 Variants
02/05/2022 14:36
May 2 (Reuters) - Aethlon Medical Inc AEMD.O :
* AETHLON MEDICAL PUBLISHES IN VITRO STUDIES DEMONSTRATING
HEMOPURIFIER RESIN BINDING OF SEVEN CLINICALLY RELEVANT COVID-19
VARIANTS
* AETHLON MEDICAL INC - VIRAL CAPTURE EFFICIENCY RANGED FROM
53%
TO 89% FOR SEVEN COVID-19 VARIANTS TESTED
Source text for Eikon: ID:nPnbrXwk4a
Further company coverage: AEMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology